Teva Pharmaceutical Industries Stock Price, News & Analysis
Company Description
Teva Pharmaceutical Industries (OTC Link: TEVJF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $52.1B.
TEVJF stock has gained 53.3% over the past year. Shares last traded at $28.36.
On a trailing twelve-month basis, Teva Pharmaceutical Industries reported revenue of $17.3B with net income of $1.4B and diluted earnings per share of $1.21. The company operates at a net profit margin of 8.2%.
This page provides a comprehensive overview of TEVJF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Teva Pharmaceutical Industries (TEVJF) stock last traded at $28.36. Over the past 12 months, the stock has gained 53.3%. At a market capitalization of $52.1B, TEVJF is classified as a large-cap stock with approximately 1.2B shares outstanding.
Latest News
SEC Filings
Teva Pharmaceutical Industries has filed 5 recent SEC filings, including 3 Form 4, 1 Form 144, 1 Form DEF 14A. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TEVJF SEC filings →
Financial Highlights
Teva Pharmaceutical Industries generated $17.3B in revenue over the trailing twelve months, retaining a 51.8% gross margin, operating income reached $2.2B (12.5% operating margin), and net income was $1.4B, reflecting a 8.2% net profit margin. Diluted earnings per share stood at $1.21. The company generated $1.6B in operating cash flow. With a current ratio of 1.04, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Short interest in Teva Pharmaceutical Industries (TEVJF) currently stands at 737.5 thousand shares, up 74.1% from the previous reporting period, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 67.8%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Teva Pharmaceutical Industries (TEVJF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges.
TEVJF Company Profile & Sector Positioning
Teva Pharmaceutical Industries (TEVJF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.